SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 496.55 |
| Enterprise Value ($M) | 396.57 |
| Book Value ($M) | 204.87 |
| Book Value / Share | 4.21 |
| Price / Book | 2.42 |
| NCAV ($M) | -42.15 |
| NCAV / Share | -0.87 |
| Price / NCAV | -11.78 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.18 |
| Return on Assets (ROA) | -0.10 |
| Return on Equity (ROE) | -0.16 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 5.74 |
| Current Ratio | 5.74 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 124.29 |
| Assets | 371.31 |
| Liabilities | 166.44 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 57.42 |
| Operating Income | -53.29 |
| Net Income | -55.19 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -27.00 |
| Cash from Investing | -32.70 |
| Cash from Financing | -198.93 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Odre 2005 Slu | 0.00 | -100.00 | |
| 13G/A | Madison Avenue Partners, LP | 17.50 | 21.38 | |
| 13D/A | Weiss Asset Management LP | |||
| 13G | Irenic Capital Management LP | 5.50 | ||
| 13G/A | Vanguard Group Inc | 7.01 | -37.23 | |
| 13G/A | BlackRock Inc. | 9.20 | -13.98 | |
| 13G/A | Baupost Group Llc/ma | 12.84 | -35.03 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 8,682 | 168,695 | 5.15 | |
| 9,790 | 184,833 | 5.30 | |
| 6,882 | 173,965 | 3.96 | |
| 12,297 | 204,860 | 6.00 | |
| 11,066 | 391,722 | 2.82 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| STRO – Sutro Biopharma, Inc. | SUPN – Supernus Pharmaceuticals, Inc. |
| TARA – Protara Therapeutics, Inc. | TCRX – TScan Therapeutics, Inc. |
| TENK – TenX Keane Acquisition |
Financial data and stock pages provided by
Fintel.io